Residual facial erythema in atopic dermatitis patients treated with dupilumab stratified by machine learning

Documenti analoghi

• Drug survival of abrocitinib compared to dupilumab in adult patients with atopic dermatitis
  di: Qingjie Hu, et al.
  Pubblicazione: (2024)
• Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity
  di: Joséphine Dupuis, et al.
  Pubblicazione: (2024)
• Severe atopic dermatitis in an Asian‐Arabic population treated with dupilumab: A retrospective observational study
  di: Radi Al Chalabi, et al.
  Pubblicazione: (2024)
• Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab
  di: Hyungdon Kook, et al.
  Pubblicazione: (2024)
• Single‐centre experience with tralokinumab in dupilumab‐experienced and naïve patients with atopic dermatitis
  di: Claire Fossati, et al.
  Pubblicazione: (2024)